Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 3, 2026Open Access

Plant-Derived Vesicle-like Nanoparticles for Cancer Therapy: From Drug Delivery to Combined Immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JZJinying ZhangYZYuan ZuoBSBo Sun

Discussion

Loading...

Member takes

Overview

Review highlights the potential of plant-derived nanoparticles in drug delivery and cancer immunotherapy, suggesting strong future applications.

Key Points

  • This research reviews the potential of plant-derived vesicle-like nanoparticles (PDVLNs) in cancer therapy.
  • Summarizes biogenesis and isolation methods of PDVLNs.
  • Explores compositions and anti-tumor mechanisms of PDVLNs.
  • Discusses engineering strategies for drug loading.
  • Reviews challenges in production and clinical translation.
  • PDVLNs show significant potential as drug delivery systems for various anti-cancer agents.
  • Evidence supports PDVLNs as effective platforms for combined cancer immunotherapy.
  • Challenges identified include production optimization and delivery efficiency.

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69a67f12f353c071a6f0ae65https://doi.org/10.3390/antiox15030311
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plant-Derived Vesicle-like Nanoparticles: The Next-Generation Drug Delivery Nanoplatforms2024 · 33 citations
  2. 2Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment2026 · 1 citations
  3. 3Green nanomedicine for cancer therapy2026
  4. 4Plant‐Derived Vesicle‐Like Nanoparticles as Promising Biotherapeutic Tools: Present and Future2023 · 296 citations
  5. 5Plant-derived nanovesicles: the intelligent nanoplatforms for therapeutics and drug delivery.2026 · 2 citations